Literature DB >> 27474124

Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma.

David F Choy1, Guiquan Jia1, Alexander R Abbas1, Katrina B Morshead1, Nicholas Lewin-Koh1, Rajiv Dua2, Pauline Rivera2, Priscilla Moonsamy2, Marcel Fontecha2, Aarthi Balasubramanyam2, Chris Santini2, Ekaterina Bassett1, Jill M Ray1, Christopher R Cabanski1, Mary S Bradley1, Romeo Maciuca1, Sofia Mosesova1, Heleen Scheerens1, Joseph R Arron3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27474124     DOI： 10.1016/j.jaci.2016.06.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Peripheral Blood Gene Expression Signatures of Eosinophilic Chronic Obstructive Pulmonary Disease.

Authors:  Jeong H Yun; Robert Chase; Margaret M Parker; Aabida Saferali; Peter J Castaldi; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Cell Mol Biol       Date:  2019-09       Impact factor: 6.914

Review 2.  Genetic Determinants in Airways Obstructive Diseases: The Case of Asthma Chronic Obstructive Pulmonary Disease Overlap.

Authors:  Aabida Saferali; Craig P Hersh
Journal:  Immunol Allergy Clin North Am       Date:  2022-06-30       Impact factor: 3.152

3.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

4.  Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents.

Authors:  Yale Jiang; Olena Gruzieva; Ting Wang; Erick Forno; Nadia Boutaoui; Tao Sun; Simon K Merid; Edna Acosta-Pérez; Inger Kull; Glorisa Canino; Josep M Antó; Jean Bousquet; Erik Melén; Wei Chen; Juan C Celedón
Journal:  Eur Respir J       Date:  2019-05-18       Impact factor: 33.795

5.  Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection.

Authors:  Matthew K O'Shea; Thomas E Fletcher; Julius Muller; Rachel Tanner; Magali Matsumiya; J Wendi Bailey; Jayne Jones; Steven G Smith; Gavin Koh; William G Horsnell; Nicholas J Beeching; James Dunbar; Duncan Wilson; Adam F Cunningham; Helen McShane
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.